Hangzhou AGS MedTech Co. Ltd. A (688581) — Working Capital to Net Assets Ratio
Hangzhou AGS MedTech Co. Ltd. A (688581) has a Working Capital to Net Assets ratio of 76.5% as of March 2026. Working capital of CN¥1.97 Billion (current assets of CN¥2.09 Billion minus current liabilities of CN¥119.39 Million) is measured against net assets of CN¥2.57 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 688581 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hangzhou AGS MedTech Co. Ltd. A Working Capital to Net Assets (2021–2025)
This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 76.5%, reflecting working capital of CN¥1.97 Billion against net assets of CN¥2.57 Billion CNY. For the complete balance sheet picture, see 688581 asset base.
Annual Working Capital to Net Assets for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Hangzhou AGS MedTech Co. Ltd. A (688581) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 77.2% | CN¥1.94 Billion | CN¥2.52 Billion | CN¥2.09 Billion | CN¥151.90 Million | ▲ +4.1 pp |
| 2024 | 73.1% | CN¥1.75 Billion | CN¥2.40 Billion | CN¥1.89 Billion | CN¥141.99 Million | ▼ -18.6 pp |
| 2023 | 91.7% | CN¥2.03 Billion | CN¥2.21 Billion | CN¥2.15 Billion | CN¥120.73 Million | ▲ +28.6 pp |
| 2022 | 63.1% | CN¥240.86 Million | CN¥381.54 Million | CN¥331.89 Million | CN¥91.03 Million | ▼ -8.2 pp |
| 2021 | 71.3% | CN¥193.57 Million | CN¥271.45 Million | CN¥262.56 Million | CN¥69.00 Million | — |